EUVIMEDOdkrijte EUVIMED
Systematische ÜbersichtMetaanalyseOpen access · CC BY 4.0

Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization

Yonglu Guo, Haohao Xu, Peng Shen, Ruijun Cai iD

Phytotherapy Research · 2025

DOI: 10.1002/ptr.70073 ↗

At a glance

Systematische Übersicht in Phytotherapy Research, 2025. Written by Yonglu Guo and 3 co-authors. Institution: Department of Respiratory and Crical Care Medicine, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China. Major MEDLINE topics: Curcumin, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms. Cited 3 times so far (Crossref); 100 references. The full text is freely available (open access, CC BY 4.0). Funded by: Heilongjiang Provincial Natural Science Foundation of China, 2021 Central Government's Plan to Support the Talent Training Project of the Reform and Development Fund of Local Universities.

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

To evaluate the efficacy and explore the potential mechanism of curcumin for the treatment and prevention of NSCLC. We searched six databases thoroughly for articles published before December 2024. Stata 15.0 software was applied for systematic review with meta‐analysis. We utilized network pharmacology, Mendelian randomization, and molecular docking techniques to investigate the pharmacological properties and potential targets of curcumin in the treatment of NSCLC. Twenty‐four studies involving 392 experimental animals were included in this study. Meta‐analysis results showed that curcumin significantly reduced tumor volume of mice ( p < 0.001) in the NSCLC group compared to the control group. Two hundred twenty‐nine curcumin target genes were predicted. 1546 NSCLC‐related genes were obtained by taking the intersection of DEGs and genes in the key module of WGCNA. Eight hub genes were identified by protein–protein interaction. The eight hub genes showed significant clinical value and were found to be negatively correlated with the majority of immune cell infiltration. Molecular docking results indicated a good binding affinity between these eight hub genes and curcumin. Mendelian randomization demonstrated a causal relationship between the AURKB level and the increased risk of NSCLC. In this study, the effectiveness of curcumin has been demonstrated in in vivo models of NSCLC by meta‐analysis. AURKB has been identified as a high‐risk target for NSCLC by network pharmacological analysis and MR for the first time. Our study provides a scientific basis for clinical applications of curcumin in NSCLC.

Subjects

MeSH terms (MEDLINE)

CurcuminCarcinoma, Non-Small-Cell LungLung NeoplasmsMendelian Randomization AnalysisAnimalsMolecular Docking SimulationHumansNetwork PharmacologyMiceProtein Interaction Maps

Author keywords

curcuminmendelian randomizationmeta‐analysisnetwork pharmacologynonsmall cell lung cancer (NSCLC)systematic review

Substances

Curcumin

Authors and institutions

  • Department of Respiratory and Crical Care Medicine, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China.
  • College of Medical Technology, Qiqihar Medical University, Qiqihar, China.
  • The First Psychiatric Hospital of Harbin, Harbin, China.
  • Department of Pharmacy, Shanghai General Hospital Jiuquan Hospital (The People's Hospital of Jiuquan), Jiuquan, China.

ORCID profiles: Ruijun Cai

Funding

  • Heilongjiang Provincial Natural Science Foundation of China
  • 2021 Central Government's Plan to Support the Talent Training Project of the Reform and Development Fund of Local Universities

Cite

APA

Guo, Y., Xu, H., Shen, P., & Cai, R. (2025). Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization. Phytotherapy Research. https://doi.org/10.1002/ptr.70073

Vancouver

Guo Y, Xu H, Shen P, Cai R. Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization. Phytotherapy Research. 2025. doi:10.1002/ptr.70073

BibTeX
@article{Guo2025,
  author = {Guo, Yonglu and Xu, Haohao and Shen, Peng and Cai, Ruijun},
  title = {Investigating the Potential of Curcumin in the Treatment of Nonsmall Cell Lung Cancer: A Systematic Review With Meta‐Analysis, Network Pharmacology, and Mendelian Randomization},
  journal = {Phytotherapy Research},
  year = {2025},
  doi = {10.1002/ptr.70073}
}
Start for free →